MicroRNA-30a inhibits epithelial-to-mesenchymal transition by targeting Snai1 and is downregulated in non-small cell lung cancer - PubMed (original) (raw)
. 2012 May 1;130(9):2044-53.
doi: 10.1002/ijc.26218. Epub 2011 Aug 8.
Affiliations
- PMID: 21633953
- DOI: 10.1002/ijc.26218
MicroRNA-30a inhibits epithelial-to-mesenchymal transition by targeting Snai1 and is downregulated in non-small cell lung cancer
Regalla Kumarswamy et al. Int J Cancer. 2012.
Abstract
MicroRNAs (miRNAs) are small non-coding RNAs which regulate gene expression by base-pairing to the 3'-UTR of the target mRNA. Recently, miRNAs have been shown to regulate cancer metastasis, however, central molecular mechanisms of this ability still need to be investigated. Epithelial to mesenchymal transition (EMT), which is characterized especially by repression of E-cadherin expression and increased cell motility, is an essential component of cancer metastasis and progression. In the present study, we found that Snai1, a known transcriptional repressor of E-cadherin and modulator of EMT, is post-transcriptionally targeted by miRNA-30a in non-small cell lung cancer (NSCLC). Consistent with this, microRNA-30a expression was found inversely proportional to the invasive potential of various NSCLC cell lines, correlating positively with E-cadherin (epithelial marker) and negatively with N-cadherin (mesenchymal marker) expression. Forced re-introduction of miR-30a significantly altered cell morphology, in vitro invasion and migration of invasive cell lines, this being paralleled by a downregulation of Snai1 and upregulation of E-cadherin expression. Using a chicken embryonic metastasis assay, we found that miR-30a suppresses in vivo distant metastasis to the lungs and liver. Finally, we screened the expression of miR-30a in 64 consecutively resected NSCLC patients and found that, in 81% of the patients, expression of miR-30a was downregulated significantly (p < 0.0001) in tumors compared to corresponding normal tissues. These results suggest that miR-30a targets Snai1, inhibits invasion and metastasis, and is downregulated in NSCLC.
Copyright © 2011 UICC.
Similar articles
- MiR-30 suppresses lung cancer cell 95D epithelial mesenchymal transition and invasion through targeted regulating Snail.
Fan MJ, Zhong YH, Shen W, Yuan KF, Zhao GH, Zhang Y, Wang SK. Fan MJ, et al. Eur Rev Med Pharmacol Sci. 2017 Jun;21(11):2642-2649. Eur Rev Med Pharmacol Sci. 2017. PMID: 28678320 Retracted. - MiR-182 inhibits the epithelial to mesenchymal transition and metastasis of lung cancer cells by targeting the Met gene.
Li Y, Zhang H, Li Y, Zhao C, Fan Y, Liu J, Li X, Liu H, Chen J. Li Y, et al. Mol Carcinog. 2018 Jan;57(1):125-136. doi: 10.1002/mc.22741. Epub 2017 Oct 16. Mol Carcinog. 2018. PMID: 28940757 - MicroRNA-30a Suppresses the Activation of Hepatic Stellate Cells by Inhibiting Epithelial-to-Mesenchymal Transition.
Zheng J, Wang W, Yu F, Dong P, Chen B, Zhou MT. Zheng J, et al. Cell Physiol Biochem. 2018;46(1):82-92. doi: 10.1159/000488411. Epub 2018 Mar 20. Cell Physiol Biochem. 2018. PMID: 29587268 - Long non-coding RNAs: How to regulate the metastasis of non-small-cell lung cancer.
Fang C, Wang L, Gong C, Wu W, Yao C, Zhu S. Fang C, et al. J Cell Mol Med. 2020 Mar;24(6):3282-3291. doi: 10.1111/jcmm.15054. Epub 2020 Feb 12. J Cell Mol Med. 2020. PMID: 32048814 Free PMC article. Review. - Role of microRNA/Epithelial-to-Mesenchymal Transition Axis in the Metastasis of Bladder Cancer.
Ashrafizadeh M, Hushmandi K, Hashemi M, Akbari ME, Kubatka P, Raei M, Koklesova L, Shahinozzaman M, Mohammadinejad R, Najafi M, Sethi G, Kumar AP, Zarrabi A. Ashrafizadeh M, et al. Biomolecules. 2020 Aug 7;10(8):1159. doi: 10.3390/biom10081159. Biomolecules. 2020. PMID: 32784711 Free PMC article. Review.
Cited by
- Targeting PCDH20 gene by microRNA-122 confers 5-FU resistance in hepatic carcinoma.
Wang W, Liu WB, Huang da B, Jia W, Ji CS, Hu B. Wang W, et al. Am J Cancer Res. 2016 Aug 1;6(8):1681-94. eCollection 2016. Am J Cancer Res. 2016. PMID: 27648358 Free PMC article. - Genetic variants in regulatory regions of microRNAs are associated with lung cancer risk.
Xie K, Wang C, Qin N, Yang J, Zhu M, Dai J, Jin G, Shen H, Ma H, Hu Z. Xie K, et al. Oncotarget. 2016 Jul 26;7(30):47966-47974. doi: 10.18632/oncotarget.10299. Oncotarget. 2016. PMID: 27374108 Free PMC article. - Differential combinatorial regulatory network analysis related to venous metastasis of hepatocellular carcinoma.
Zeng L, Yu J, Huang T, Jia H, Dong Q, He F, Yuan W, Qin L, Li Y, Xie L. Zeng L, et al. BMC Genomics. 2012;13 Suppl 8(Suppl 8):S14. doi: 10.1186/1471-2164-13-S8-S14. Epub 2012 Dec 17. BMC Genomics. 2012. PMID: 23282077 Free PMC article. - Cadmium exposure upregulates SNAIL through miR-30 repression in human lung epithelial cells.
Tanwar VS, Zhang X, Jagannathan L, Jose CC, Cuddapah S. Tanwar VS, et al. Toxicol Appl Pharmacol. 2019 Jun 15;373:1-9. doi: 10.1016/j.taap.2019.04.011. Epub 2019 Apr 16. Toxicol Appl Pharmacol. 2019. PMID: 30998937 Free PMC article. - Post-transcriptional regulation of human breast cancer cell proteome by unliganded estrogen receptor β via microRNAs.
Nassa G, Tarallo R, Giurato G, De Filippo MR, Ravo M, Rizzo F, Stellato C, Ambrosino C, Baumann M, Lietzèn N, Nyman TA, Weisz A. Nassa G, et al. Mol Cell Proteomics. 2014 Apr;13(4):1076-90. doi: 10.1074/mcp.M113.030403. Epub 2014 Feb 13. Mol Cell Proteomics. 2014. PMID: 24525454 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials